NEURO REVA: what changed
What changed
NEURO REVA
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€253,492
2024 · €258,359-€4,868
Equity
€1.2m
2024 · €1.1m+€100,610
Cash
€644,638
2024 · €812,614-€167,976
Balance sheet total
€1.2m
2024 · €1.1m+€101,239
Largest movements
Assets
- Current investments +€307,514
new in 2025: €307,514
- Cash -€167,976
down €167,976 (-20.7%), from €812,614 to €644,638
mainly Current investments (-€307,514) and Contributions, distributions and other (-€152,882)
- Tangible fixed assets -€47,731
down €47,731 (-16.3%), from €292,282 to €244,551
Equity and liabilities
- Reserves +€100,610
up €100,610 (+9.2%), from €1.1m to €1.2m
Income statement
- Gross operating margin -€6,728
down €6,728 (-1.6%), from €429,712 to €422,984
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€258,359
Gross operating margin
-€6,728
Depreciation
+€2,361
Other operating charges
-€74
Financial income
+€217
Financial charges
-€2,955
Taxes
+€2,312
Result 2025
€253,492
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€294,878
Investment
-€309,972
Financing
-€152,882
Cash 2024
€812,614
From operations (derived)
+€294,878
Net result for the year
+€253,492
Depreciation
+€50,189
Receivables within one year
-€9,004
Smaller working-capital items
-€461
Trade debts
-€1,175
Tax, wage and social debts
+€1,837
Investment (derived)
-€309,972
Investment in fixed assets (net)
-€2,458
Current investments
-€307,514
Financing
-€152,882
Contributions, distributions and other
-€152,882
Cash 2025
€644,638
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,128,403 | €1,229,642 | +€101,239 | +9.0% |
| Fixed assets | 21/28 | €292,522 | €244,791 | -€47,731 | -16.3% |
| Tangible fixed assets | 22/27 | €292,282 | €244,551 | -€47,731 | -16.3% |
| Land and buildings | 22 | €236,770 | €218,569 | -€18,201 | -7.7% |
| Plant, machinery and equipment | 23 | €9,184 | €2,268 | -€6,916 | -75.3% |
| Furniture and vehicles | 24 | €21,929 | €3,340 | -€18,590 | -84.8% |
| Other tangible fixed assets | 26 | €24,398 | €20,373 | -€4,025 | -16.5% |
| Financial fixed assets | 28 | €240 | €240 | = | 0.0% |
| Current assets | 29/58 | €835,881 | €984,851 | +€148,970 | +17.8% |
| Amounts receivable within one year | 40/41 | €17,455 | €26,459 | +€9,004 | +51.6% |
| Trade receivables | 40 | €15,948 | €4,850 | -€11,098 | -69.6% |
| Other amounts receivable | 41 | €1,506 | €21,609 | +€20,102 | +1,334% |
| Current investments | 50/53 | - | €307,514 | +€307,514 | |
| Cash at bank and in hand | 54/58 | €812,614 | €644,638 | -€167,976 | -20.7% |
| Deferred charges and accrued income | 490/1 | €5,812 | €6,240 | +€427 | +7.4% |
| Total equity and liabilities | 10/49 | €1,128,403 | €1,229,642 | +€101,239 | +9.0% |
| Equity | 10/15 | €1,116,507 | €1,217,116 | +€100,610 | +9.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €1,097,907 | €1,198,516 | +€100,610 | +9.2% |
| Distributable reserves | 133 | €1,097,907 | €1,198,516 | +€100,610 | +9.2% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €11,896 | €12,525 | +€629 | +5.3% |
| Amounts payable within one year | 42/48 | €11,863 | €12,525 | +€663 | +5.6% |
| Trade debts | 44 | €3,920 | €2,745 | -€1,175 | -30.0% |
| Suppliers | 440/4 | €3,920 | €2,745 | -€1,175 | -30.0% |
| Taxes, remuneration and social security | 45 | €7,943 | €9,781 | +€1,837 | +23.1% |
| Taxes | 450/3 | €7,943 | €9,781 | +€1,837 | +23.1% |
| Accrued charges and deferred income | 492/3 | €34 | €0 | -€34 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €52,550 | €50,189 | -€2,361 | -4.5% |
| Other operating charges | 640/8 | €2,705 | €2,780 | +€74 | +2.7% |
| Gross operating margin | 9900 | €429,712 | €422,984 | -€6,728 | -1.6% |
| Operating profit (loss) | 9901 | €374,457 | €370,015 | -€4,441 | -1.2% |
| Financial income | 75/76B | €73 | €290 | +€217 | +299% |
| Recurring financial income | 75 | €73 | €290 | +€217 | +299% |
| Financial charges | 65/66B | €1,197 | €4,153 | +€2,955 | +247% |
| Recurring financial charges | 65 | €1,197 | €4,153 | +€2,955 | +247% |
| Profit (loss) for the period before taxes | 9903 | €373,332 | €366,153 | -€7,179 | -1.9% |
| Income taxes | 67/77 | €114,973 | €112,661 | -€2,312 | -2.0% |
| Profit (loss) for the period | 9904 | €258,359 | €253,492 | -€4,868 | -1.9% |
| Profit (loss) for the period to be appropriated | 9905 | €258,359 | €253,492 | -€4,868 | -1.9% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.